Photo of Elisha Kobre

Elisha Kobre, a highly experienced former federal prosecutor, is a partner in the firm’s Government Enforcement and Investigations and Litigation practice groups. He principally represents corporations, executives, high net worth individuals, and financial institutions in criminal investigations and trials, regulatory enforcement proceedings, and complex civil litigation.  He also conducts internal investigations, transactional diligence, and advises on compliance matters. Elisha has particular experience in matters involving securities and commodities fraud, FCPA enforcement, healthcare fraud, and criminal and civil asset forfeiture.

The SEC’s Division of Examinations last week announced its 2023 “examination priorities.” The division’s annual announcement of priorities provides valuable insight into the categories of registrants most likely to be the subject of an SEC examination and the issues most likely to be a focus of those examinations. In determining its priorities, the division employs

The heavily publicized announcement by New York federal prosecutors of the first-ever charges for insider trading in digital assets — non-fungible tokens, or “NFTs” in particular — is a significant but somewhat confusing development for the crypto community and beyond. There is nothing novel about applying well-established law to the abuse of confidential, insider  information

Until last month, government enforcement and regulatory scrutiny of fraud and other misconduct relating to COVID-19 relief programs was generally limited to end recipients of the relief. These efforts have mostly been directed to fraud in connection with the Paycheck Protection Program (PPP), a nearly $1 trillion business loan program administered by the Small Business

The Second Circuit last week in United States v. Halkbank significantly limited the immunity granted under the ForeignSecond Circuit Broadly Interprets Exception to Immunity for Foreign Entities Under the Foreign Sovereign Immunities Act Sovereign Immunities Act (FSIA) by giving a broad interpretation to the act’s “commercial activity” exception. Entities that could otherwise claim FSIA immunity should be aware that the commercial activity exception is likely to present a significant obstacle